Cargando…

Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era

Detalles Bibliográficos
Autores principales:	Madeddu, G, Fois, AG, Calia, GM, Becciu, F, Piras, B, Fiori, ML, Spada, V, Lovigu, C, Mannazzu, M, Pirina, P, Mura, MS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113019/ http://dx.doi.org/10.1186/1758-2652-13-S4-P232

Ejemplares similares

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic
por: Onigbogi, MO, et al.
Publicado: (2010)

Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
por: Kojic, EM, et al.
Publicado: (2009)

Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010)

Relationship between dynamics of Epstein-Barr virus and immune activation in HIV-1 infected subjects in the HAART era
por: Cattelan, AM, et al.
Publicado: (2010)

High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan
por: Salami, O, et al.
Publicado: (2010)

The prognosis of patients with dissociated virological and immunological responses to HAART
por: Jevtovic, DJ, et al.
Publicado: (2010)

Prevalence of HPV in the oral cavity of HIV seropositive Indian women undergoing HAART
por: Mukherjee, Jaya, et al.
Publicado: (2014)

Reliability and Usefulness of Different Biomarkers of Oxidative Stress in Chronic Obstructive Pulmonary Disease
por: Zinellu, Elisabetta, et al.
Publicado: (2020)

HIV-1 infection in dendritic cells in HAART suppressed patients
por: Maldonado, lrvin M, et al.
Publicado: (2006)

Mesenteric fat thickness in a group of HIV patients on HAART
por: Lee, SS, et al.
Publicado: (2010)

Characteristic of HIV/AIDS infected patients at the detection and HAART initiation
por: Holban, Tiberiu, et al.
Publicado: (2014)

Factors associated with treatment modification during the first year of contemporary HAART
por: Martin, N, et al.
Publicado: (2010)

High preterm delivery rates associated with initiation of HAART during pregnancy
por: Taylor, GP, et al.
Publicado: (2010)

Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
por: Tossonian, HK, et al.
Publicado: (2010)

Five-year outcomes of HAART at a non-governmental treatment center in Lima, Peru
por: Castillo, N, et al.
Publicado: (2010)

Effective HAART reduces the incidence of high grade cervical neoplasia in HIV positive women
por: Morris-Harris, Deborah, et al.
Publicado: (2012)

Respiratory Symptoms and Airway Obstruction in HIV-Infected Subjects in the HAART Era
por: George, M. Patricia, et al.
Publicado: (2009)

Treatment of COPD and COPD–heart failure comorbidity in primary care in different stages of the disease
por: Pirina, Pietro, et al.
Publicado: (2020)

Evolution of tuberculosis/HIV co-infection in California during the HAART Era, 1996-2007
por: Metcalfe, John, et al.
Publicado: (2010)

Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART
por: Uglietti, A, et al.
Publicado: (2010)

Effectiveness of pegylated interferon alfa plus HAART in HIV/HBV treatment-naïve coinfected patients
por: Mata-Marín, JA, et al.
Publicado: (2010)

Efficacy and safety of therapy of chronic hepatitis B with telbivudine (LdT) in patients with HIV-infection without HAART
por: Tsarenko, SP, et al.
Publicado: (2010)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

Risk of death among Italian AIDS cases with AIDS-defining cancers in the post-HAART era
por: Serraino, D, et al.
Publicado: (2009)

Impact of timing HAART initiation on immune status and clinical course in the cohort of the German competence network for HIV/AIDS
por: Plettenberg, A, et al.
Publicado: (2010)

Impact of short term HAART initiated during the acute or chronic stage on SIV infection of the male genital tract
por: Moreau, Marina, et al.
Publicado: (2010)

Home visiting to an HIV positive patient prior to initiation of HAART has Lasting impact on their adherence. TASO Experience
por: Odeke, Emmanuel, et al.
Publicado: (2010)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
por: Agyingi, L, et al.
Publicado: (2012)

Inhospital mortality of patients with submassive pulmonary embolism submitted to thrombolytic therapy in a multicenter study
por: Volschan, A, et al.
Publicado: (2005)

Prevalence of tuberculosis in HIV in Ethiopia in early HAART era: retrospective analysis
por: Gudina, Esayas Kebede, et al.
Publicado: (2013)

Pattern of cancer risk in persons with AIDS in Italy in the HAART era
por: Dal Maso, L, et al.
Publicado: (2009)

Does feedback of medication execution using MEMS caps aid adherence to HAART?: the MEMRI study (MEMS as Realistic Intervention)
por: Davies, S, et al.
Publicado: (2010)

Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment
por: Perez-Molina, JA, et al.
Publicado: (2010)

Factors associated with non-adherence to HAART in HIV-positive pregnant women during pregnancy, peri- and postpartum in Lima, Peru
por: Tejada, Romina, et al.
Publicado: (2010)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
por: Kløverpris, H, et al.
Publicado: (2012)

P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART
por: Montes, M, et al.
Publicado: (2009)

Role of procalcitonin as a diagnostic and prognostic marker of infectious diseases in the emergency department: preliminary data
por: Magrini, L, et al.
Publicado: (2010)

HAART restores the frequency of regulatory T cells (Tregs) among HIV/AIDS patients
por: Suthandhira, M, et al.
Publicado: (2014)

The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART)
por: Cassetti, I, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h2ulc78vn9kumiujffhu2nsmbd